DK3340966T3 - Insulinsammensætninger med hurtig virkning - Google Patents

Insulinsammensætninger med hurtig virkning Download PDF

Info

Publication number: DK3340966T3
Authority: DK; Denmark
Prior art keywords: rapid; acting insulin; insulin compositions; compositions; acting
Prior art date: 2015-08-27

Application number

DK16771021.9T

Other languages

English (en)

Inventor

Michael Patrick Akers

Michael Edward Christe

Thomas Andrew Hardy

Ranajoy Majumdar

Chi A Nguyen

Chad D Paavola

Virender Kumar Sarin

Nanette Elizabeth Schulte

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-08-27

Filing date

2016-08-19

Publication date

2022-10-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57003563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3340966(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-08-19 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2022-10-24 Application granted granted Critical

2022-10-24 Publication of DK3340966T3 publication Critical patent/DK3340966T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Obesity (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK16771021.9T 2015-08-27 2016-08-19 Insulinsammensætninger med hurtig virkning DK3340966T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562210469P	2015-08-27	2015-08-27
PCT/US2016/047723 WO2017034956A1 (en)	2015-08-27	2016-08-19	Rapid-acting insulin compositions

Publications (1)

Publication Number	Publication Date
DK3340966T3 true DK3340966T3 (da)	2022-10-24

Family

ID=57003563

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK16771021.9T DK3340966T3 (da)	2015-08-27	2016-08-19	Insulinsammensætninger med hurtig virkning

Country Status (39)

Country	Link
US (3)	US9901623B2 (da)
EP (2)	EP4169505A1 (da)
JP (2)	JP6359780B2 (da)
KR (1)	KR102018998B1 (da)
CN (1)	CN107920992B (da)
AR (1)	AR105712A1 (da)
AU (1)	AU2016310475B2 (da)
BR (1)	BR112018001755A2 (da)
CA (1)	CA2994427C (da)
CL (1)	CL2018000503A1 (da)
CO (1)	CO2018002026A2 (da)
CR (1)	CR20180118A (da)
DK (1)	DK3340966T3 (da)
DO (1)	DOP2018000059A (da)
EA (1)	EA033396B1 (da)
EC (1)	ECSP18014922A (da)
ES (1)	ES2928664T3 (da)
FI (1)	FI3340966T3 (da)
HR (1)	HRP20221367T1 (da)
HU (1)	HUE060626T2 (da)
IL (1)	IL256939B (da)
JO (1)	JO3749B1 (da)
LT (1)	LT3340966T (da)
MA (1)	MA42701B1 (da)
MD (1)	MD3340966T2 (da)
MX (1)	MX2018002482A (da)
MY (1)	MY195781A (da)
NZ (1)	NZ739338A (da)
PE (1)	PE20180782A1 (da)
PH (1)	PH12018500422B1 (da)
PL (1)	PL3340966T3 (da)
PT (1)	PT3340966T (da)
RS (1)	RS63731B1 (da)
SV (1)	SV2018005643A (da)
TN (1)	TN2018000056A1 (da)
TW (1)	TWI614025B (da)
UA (1)	UA120142C2 (da)
WO (1)	WO2017034956A1 (da)
ZA (1)	ZA201800511B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX360107B (es)	2012-11-13	2018-10-23	Adocia	Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido.
TW201630622A (zh) *	2014-12-16	2016-09-01	美國禮來大藥廠	速效胰島素組合物
JO3749B1 (ar) *	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
MA50496A (fr) *	2017-06-01	2020-09-09	Lilly Co Eli	Compositions d'insuline à action rapide
US11510967B2 (en)	2017-09-08	2022-11-29	Eli Lilly And Company	Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
WO2019193353A1 (en) *	2018-04-04	2019-10-10	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
IL277720B2 (en) *	2018-04-04	2024-03-01	Arecor Ltd	Medical infusion pump system for the delivery of an insulin compound
EP3773472A1 (en) *	2018-04-04	2021-02-17	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083984A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
CA3112986C (en) *	2018-09-18	2024-06-18	Eli Lilly And Company	Erbumine salt of treprostinil
US20220249619A1 (en) *	2019-07-12	2022-08-11	Novo Nordisk A/S	High concentration insulin formulation
CN115697379A (zh) *	2020-06-30	2023-02-03	江苏恒瑞医药股份有限公司	速效胰岛素组合物及其医药用途

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2740953A1 (de)	1977-09-12	1979-03-22	Thera Ges Fuer Patente	Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
EP0018609B1 (de)	1979-04-30	1983-09-21	Hoechst Aktiengesellschaft	Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
ZA821243B (en) *	1981-03-10	1983-01-26	Novo Industri As	Stabilized insulin preparation and method for their production
FI78616C (fi)	1982-02-05	1989-09-11	Novo Industri As	Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
PH25772A (en)	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
DK503386D0 (da) *	1986-10-20	1986-10-20	Novo Industri As	Peptidpraeparater
NZ223630A (en)	1987-02-25	1989-11-28	Novo Industri As	Insulin derivative and pharmaceutical compositions
US5716927A (en)	1988-12-23	1998-02-10	Novo Nordisk A/S	Insulin analogs having a modified B-chain
JPH04502465A (ja)	1988-12-23	1992-05-07	ノボ　ノルディスク　アクティーゼルスカブ	ヒトインシュリン類似物質
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
JPH11292787A (ja) *	1995-08-15	1999-10-26	Asahi Chem Ind Co Ltd	生理活性ペプチドを含有する経粘膜投与製剤
US5912014A (en)	1996-03-15	1999-06-15	Unigene Laboratories, Inc.	Oral salmon calcitonin pharmaceutical products
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
AUPO066096A0 (en)	1996-06-26	1996-07-18	Peptide Delivery Systems Pty Ltd	Oral delivery of peptides
JPH10251146A (ja)	1997-03-11	1998-09-22	Toray Ind Inc	糖尿病性神経障害の治療方法
AU1870099A (en) *	1998-01-09	1999-07-26	Novo Nordisk A/S	Stabilised insulin compositions
WO2000043034A2 (en)	1999-01-26	2000-07-27	Eli Lilly And Company	Monodisperse hexameric acylated insulin analog formulations
AU779798C (en)	1999-11-15	2005-11-17	Hanamaraddi T. Gangal	Dextrose and insulin fluid formulation for intravenous infusion
US20020141946A1 (en)	2000-12-29	2002-10-03	Advanced Inhalation Research, Inc.	Particles for inhalation having rapid release properties
DE10114178A1 (de)	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
EP1506230B1 (en)	2002-05-07	2011-01-19	Novo Nordisk A/S	Soluble formulations comprising monomeric insulin and acylated insulin
DE10227232A1 (de)	2002-06-18	2004-01-15	Aventis Pharma Deutschland Gmbh	Saure Insulinzubereitungen mit verbesserter Stabilität
WO2005009446A1 (en) *	2003-07-17	2005-02-03	Cotherix, Inc.	Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
KR101161889B1 (ko) *	2003-12-16	2012-07-02	유나이티드 쎄러퓨틱스 코포레이션	허혈성 병변의 치료 및 예방을 위한 트레프로스티닐의 용도
US20080090753A1 (en)	2004-03-12	2008-04-17	Biodel, Inc.	Rapid Acting Injectable Insulin Compositions
US7279457B2 (en)	2004-03-12	2007-10-09	Biodel, Inc.	Rapid acting drug delivery compositions
US7879909B2 (en)	2004-04-12	2011-02-01	United Therapeutics Corporation	Use of Treprostinil to treat neuropathic diabetic foot ulcers
ES2428510T3 (es) *	2005-02-02	2013-11-08	Novo Nordisk A/S	Derivados de insulina
WO2006082205A1 (en) *	2005-02-02	2006-08-10	Novo Nordisk A/S	Insulin derivatives
US8084420B2 (en)	2005-09-29	2011-12-27	Biodel Inc.	Rapid acting and long acting insulin combination formulations
US20070086952A1 (en)	2005-09-29	2007-04-19	Biodel, Inc.	Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
EP1931805A2 (en) *	2005-09-30	2008-06-18	Perlegen Sciences, Inc.	Methods and compositions for screening and treatment of disorders of blood glucose regulation
DE102006047613A1 (de) *	2006-10-07	2008-04-10	Sanofi-Aventis Deutschland Gmbh	Peristaltische Mikropumpe mit wechselbarem Pumpenkopf
DE102006047538A1 (de) *	2006-10-07	2008-04-10	Sanofi-Aventis Deutschland Gmbh	Medikamentendosiersystem mittels Mikropumpe
ES2744384T3 (es)	2007-06-13	2020-02-24	Novo Nordisk As	Formulación farmacéutica que comprende un derivado de insulina
EP2545920A1 (en) *	2007-08-22	2013-01-16	Abbott GmbH & Co. KG	Therapy for complications of diabetes
TWI394580B (zh)	2008-04-28	2013-05-01	Halozyme Inc	超快起作用胰島素組成物
TWI451876B (zh) *	2008-06-13	2014-09-11	Lilly Co Eli	聚乙二醇化之離脯胰島素化合物
DK2626093T3 (da)	2008-08-28	2014-02-24	Hoffmann La Roche	Anordning til øget subkutan insulinabsorption
US9060927B2 (en)	2009-03-03	2015-06-23	Biodel Inc.	Insulin formulations for rapid uptake
US20120094902A1 (en)	2009-03-27	2012-04-19	Adocia	Fast-acting insulin formulation
FR2943538B1 (fr)	2009-03-27	2011-05-20	Adocia	Formulation a action rapide d'insuline recombinante humaine
KR101775000B1 (ko)	2009-06-26	2017-09-04	노보 노르디스크 에이/에스	인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
CN102655866B (zh)	2009-11-13	2013-11-13	东丽株式会社	糖尿病的治疗或预防药
EP2590667A4 (en)	2010-07-07	2013-11-27	Biodel Inc	COMPOSITIONS AND METHODS FOR MODULATING THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INSULIN
AU2011343360A1 (en)	2010-12-14	2013-06-06	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and an amino acid
EP2720713A2 (en)	2011-06-17	2014-04-23	Halozyme, Inc.	Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
US9993529B2 (en)	2011-06-17	2018-06-12	Halozyme, Inc.	Stable formulations of a hyaluronan-degrading enzyme
US20130231281A1 (en)	2011-11-02	2013-09-05	Adocia	Rapid acting insulin formulation comprising an oligosaccharide
JP5912426B2 (ja) *	2011-11-07	2016-04-27	ヤマハ発動機株式会社	リニアコンベア
LT3130347T (lt)	2011-12-30	2019-10-25	Halozyme Inc	Ph20 polipeptido variantai, kompozicijos ir jų panaudojimas
US9381247B2 (en) *	2012-04-16	2016-07-05	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US9399065B2 (en)	2012-04-16	2016-07-26	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
WO2013177565A1 (en)	2012-05-25	2013-11-28	Amylin Pharmaceuticals, Llc	Insulin-pramlintide compositions and methods for making and using them
US20150065423A1 (en) *	2013-08-30	2015-03-05	Perosphere, Inc.	Rapid acting injectable formulations
CA2936563A1 (en)	2014-01-13	2015-07-16	Thermalin Diabetes, Llc	Rapid action insulin formulations and pharmaceutical delivery systems
US20150273022A1 (en)	2014-02-10	2015-10-01	Biodel Inc.	Stabilized ultra-rapid-acting insulin formulations
TWI685348B (zh) *	2014-05-08	2020-02-21	美國禮來大藥廠	速效胰島素組合物
TW201630622A (zh)	2014-12-16	2016-09-01	美國禮來大藥廠	速效胰島素組合物
EP3328388B1 (en)	2015-07-28	2023-12-27	Eli Lilly and Company	A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin
JO3749B1 (ar) *	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول

2016
- 2016-08-14 JO JOP/2016/0183A patent/JO3749B1/ar active
- 2016-08-16 AR ARP160102504A patent/AR105712A1/es not_active Application Discontinuation
- 2016-08-16 TW TW105126161A patent/TWI614025B/zh active
- 2016-08-19 MY MYPI2018700714A patent/MY195781A/en unknown
- 2016-08-19 US US15/241,412 patent/US9901623B2/en active Active
- 2016-08-19 WO PCT/US2016/047723 patent/WO2017034956A1/en active Application Filing
- 2016-08-19 BR BR112018001755-8A patent/BR112018001755A2/pt active Search and Examination
- 2016-08-19 KR KR1020187005546A patent/KR102018998B1/ko active IP Right Grant
- 2016-08-19 CR CR20180118A patent/CR20180118A/es unknown
- 2016-08-19 HR HRP20221367TT patent/HRP20221367T1/hr unknown
- 2016-08-19 JP JP2017545409A patent/JP6359780B2/ja active Active
- 2016-08-19 MA MA42701A patent/MA42701B1/fr unknown
- 2016-08-19 TN TNP/2018/000056A patent/TN2018000056A1/en unknown
- 2016-08-19 EA EA201890343A patent/EA033396B1/ru unknown
- 2016-08-19 ES ES16771021T patent/ES2928664T3/es active Active
- 2016-08-19 PL PL16771021.9T patent/PL3340966T3/pl unknown
- 2016-08-19 UA UAA201801732A patent/UA120142C2/uk unknown
- 2016-08-19 EP EP22200405.3A patent/EP4169505A1/en not_active Withdrawn
- 2016-08-19 RS RS20221041A patent/RS63731B1/sr unknown
- 2016-08-19 MX MX2018002482A patent/MX2018002482A/es unknown
- 2016-08-19 CN CN201680048530.0A patent/CN107920992B/zh active Active
- 2016-08-19 HU HUE16771021A patent/HUE060626T2/hu unknown
- 2016-08-19 LT LTEPPCT/US2016/047723T patent/LT3340966T/lt unknown
- 2016-08-19 NZ NZ739338A patent/NZ739338A/en unknown
- 2016-08-19 DK DK16771021.9T patent/DK3340966T3/da active
- 2016-08-19 EP EP16771021.9A patent/EP3340966B1/en active Active
- 2016-08-19 MD MDE20180654T patent/MD3340966T2/ro unknown
- 2016-08-19 PT PT167710219T patent/PT3340966T/pt unknown
- 2016-08-19 AU AU2016310475A patent/AU2016310475B2/en active Active
- 2016-08-19 CA CA2994427A patent/CA2994427C/en active Active
- 2016-08-19 PE PE2018000246A patent/PE20180782A1/es unknown
- 2016-08-19 FI FIEP16771021.9T patent/FI3340966T3/fi active
2018
- 2018-01-11 US US15/868,272 patent/US10925931B2/en active Active
- 2018-01-15 IL IL25693918A patent/IL256939B/en active IP Right Grant
- 2018-01-24 ZA ZA2018/00511A patent/ZA201800511B/en unknown
- 2018-02-23 CO CONC2018/0002026A patent/CO2018002026A2/es unknown
- 2018-02-23 DO DO2018000059A patent/DOP2018000059A/es unknown
- 2018-02-26 PH PH12018500422A patent/PH12018500422B1/en unknown
- 2018-02-26 CL CL2018000503A patent/CL2018000503A1/es unknown
- 2018-02-27 SV SV2018005643A patent/SV2018005643A/es unknown
- 2018-02-27 EC ECIEPI201814922A patent/ECSP18014922A/es unknown
- 2018-06-20 JP JP2018117015A patent/JP6935364B2/ja active Active
2021
- 2021-02-19 US US17/180,100 patent/US20210169988A1/en active Pending

Also Published As

Publication number	Publication date
MD3340966T2 (ro)	2023-04-30
PE20180782A1 (es)	2018-05-07
US20170056478A1 (en)	2017-03-02
JO3749B1 (ar)	2021-01-31
JP6359780B2 (ja)	2018-07-18
RS63731B1 (sr)	2022-12-30
ECSP18014922A (es)	2018-04-30
LT3340966T (lt)	2022-11-25
IL256939A (en)	2018-03-29
AU2016310475A1 (en)	2018-02-15
TWI614025B (zh)	2018-02-11
AU2016310475B2 (en)	2018-10-18
CN107920992A (zh)	2018-04-17
MX2018002482A (es)	2018-06-15
EP3340966A1 (en)	2018-07-04
PT3340966T (pt)	2022-12-05
DOP2018000059A (es)	2018-04-15
US20210169988A1 (en)	2021-06-10
KR20180033276A (ko)	2018-04-02
ZA201800511B (en)	2019-07-31
IL256939B (en)	2019-10-31
MA42701A (fr)	2018-07-04
PL3340966T3 (pl)	2023-01-30
US20180140676A1 (en)	2018-05-24
HRP20221367T1 (hr)	2023-01-06
CL2018000503A1 (es)	2018-08-03
HUE060626T2 (hu)	2023-03-28
JP6935364B2 (ja)	2021-09-15
US10925931B2 (en)	2021-02-23
CO2018002026A2 (es)	2018-05-21
TW201717997A (zh)	2017-06-01
EA201890343A1 (ru)	2018-07-31
JP2018172404A (ja)	2018-11-08
UA120142C2 (uk)	2019-10-10
WO2017034956A1 (en)	2017-03-02
CA2994427C (en)	2019-07-09
KR102018998B1 (ko)	2019-09-05
AR105712A1 (es)	2017-11-01
US9901623B2 (en)	2018-02-27
CR20180118A (es)	2018-03-20
ES2928664T3 (es)	2022-11-21
EA033396B1 (ru)	2019-10-31
PH12018500422B1 (en)	2022-04-01
SV2018005643A (es)	2018-10-09
JP2018507869A (ja)	2018-03-22
NZ739338A (en)	2019-06-28
TN2018000056A1 (en)	2019-07-08
MY195781A (en)	2023-02-13
EP4169505A1 (en)	2023-04-26
EP3340966B1 (en)	2022-10-12
FI3340966T3 (fi)	2023-01-13
MA42701B1 (fr)	2023-01-31
BR112018001755A2 (pt)	2018-09-18
CA2994427A1 (en)	2017-03-02
CN107920992B (zh)	2021-06-18
PH12018500422A1 (en)	2018-08-29

Publication	Publication Date	Title
DK3340966T3 (da)	2022-10-24	Insulinsammensætninger med hurtig virkning
IL248350B (en)	2020-03-31	Fast-acting insulin preparations
EP3337502A4 (en)	2019-01-23	STABLE ANTI-IFNAR1 FORMULATION
DK3361870T3 (da)	2020-05-11	Fungicidsammensætninger
DK3233108T3 (da)	2022-04-11	Hurtigtvirkende insulinsammensætninger
EP3398996A4 (en)	2019-07-31	COMPOSITION
DK3250182T3 (da)	2023-06-26	Dispergible sammensætninger
PT3261437T (pt)	2019-11-29	Compostos e composições fungicidas
EP3395887C0 (en)	2024-08-28	Fluororubber composition
DK3331498T3 (da)	2020-06-15	Nasalsammensætning
DK3393254T3 (da)	2021-07-26	Sammensætning
EP3369418A4 (en)	2019-07-31	COMPOSITION
DK3322295T3 (da)	2022-12-19	Sammensætning
DK3337322T3 (da)	2020-12-07	Fungicidsammensætninger
BR112017016240A2 (pt)	2018-03-27	composição
LT3359185T (lt)	2022-06-27	Priešnavikinė kompozicija
DK3157510T3 (da)	2019-07-01	Antimikrobielle sammensætninger med brusemidler
IL270975A (en)	2020-01-30	Fast-acting insulin preparations